FEMY
FEMY
NASDAQ · Health Care

Femasys Inc

$0.48
-0.02 (-3.15%)
As of Mar 29, 10:53 PM ET ·
Financial Highlights (FY 2026)
Revenue
4.20M
Net Income
-48,534,888
Gross Margin
66.5%
Profit Margin
-1,155.0%
Rev Growth
+11.4%
D/E Ratio
2.35
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 66.5% 66.5% 40.5% 40.5%
Operating Margin -1,091.7% -982.6% 15.3% 17.8%
Profit Margin -1,155.0% -1,097.3% 10.7% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.20M 3.78M 15.13M 13.23M
Gross Profit 2.80M 2.51M 6.13M 5.36M
Operating Income -45,901,995 -37,100,849 2.32M 2.35M
Net Income -48,534,888 -39,228,917 1.62M 1.76M
Gross Margin 66.5% 66.5% 40.5% 40.5%
Operating Margin -1,091.7% -982.6% 15.3% 17.8%
Profit Margin -1,155.0% -1,097.3% 10.7% 13.3%
Rev Growth +11.4% +11.4% -2.3% +23.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.39M 10.39M 1.56M 1.37M
Total Equity 4.43M 4.43M 10.41M 9.80M
D/E Ratio 2.35 2.35 0.15 0.14
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -45,111,599 -38,487,668 3.07M 2.96M
Free Cash Flow 2.53M 2.28M